期刊文献+

肿瘤精准药学发展简史 被引量:1

A brief history of the development of tumor precision pharmacy
下载PDF
导出
摘要 肿瘤精准药学可为恶性肿瘤患者提供精确、高效、安全和经济的治疗方案。肿瘤分子靶向治疗药物以及联合应用多种药物治疗是未来恶性肿瘤治疗研究的主要方向,将为恶性肿瘤治疗带来更多的选择和更大的希望。本文简要介绍肿瘤精准药学的定义和发展历史。 Tumor precision pharmacy can provide precise, efficient, safe and economical treatment for patients. Targeted drugs and the combination of several therapies are the main direction for future cancer research, which will bring in more choices and greater hope for the treatment of tumor. In this paper, we review the definition and brief history of tumor precision pharmacy.
出处 《上海医药》 CAS 2018年第5期3-4,9,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 肿瘤 精准药学 治疗 tumor precision pharmacy treatment
  • 相关文献

参考文献2

二级参考文献38

  • 1Kurella VB,Gali R.Structure guided homology model based design and engineering of mouse antibodies for humanization[J].Bioinformation,2014,10(4):180-186.
  • 2Parrena PWHI,Lugovskoy AA.Therapeutic antibody engineering[J].MAbs,2013,5(2):175-177.
  • 3Duvall M,Bradley N,Fiorini RN.A novel platform to produce human monoclonal antibodies:the next generation of therapeutic human monoclonal antibodies discovery[J].MAbs,2011,3(2):203-208.
  • 4Dantas-Barbosa C,de Macedo Brigido M,Maranhao AQ.Antibody phage display libraries:contributions to oncology[J].Int J Mol Sci,2012,13(5):5420-5440.
  • 5Hoffman LM,Gore L.Blinatumomab,a bi-specific anti-CD19/CD3 Bi TE?antibody for the treatment of acute lymphoblastic leukemia:perspectives and current pediatric applications[J].Front Oncol,2014,4:63.
  • 6Gleason MK,Ross JA,Warlick ED,Lund TC,Verneris MR,Wiernik A,et al.CD16x CD33 Bispecific killer cell engager(Bi KE)activates NK cells against primary MDS and MDSC CD33+targets[J].Blood,2014,123(19):3016-3026.
  • 7Han EQ,Li XL,Wang CR,Li TF,Han SY.Chimeric antigen receptor-engineered T cells for cancer immunotherapy:progress and challenges[J].J Hematol Oncol,2013,6:47.
  • 8Shi H,Sun M,Liu L,Wang Z.Chimeric antigen receptor for adoptive immunotherapy of cancer:latest research and future prospects[J].Mol Cancer,2014,13:219.
  • 9Leavy O.Therapeutic antibodies:past,present and future[J].Nat Rev Immunol,2010,10(5):297.
  • 10Liu JK.The history of monoclonal antibody development-progress,remaining challenges and future innovations[J].Ann Med Surg(Lond),2014,3(4):113-116.

共引文献32

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部